Inhibitory Effects of exogenous GLP-1 on gastric emptying increased by Hyperglycemia

被引：0
|
作者：
Kahl, S. [1 ]
机构：
[1] Univ Dusseldorf, Deutsch Diabet Zentrum, Inst Klin Diabetol, Leibniz Zentrum Diabet Forsch, D-40225 Dusseldorf, Germany
来源：
DIABETOLOGE | 2015年 / 11卷 / 05期
关键词：
D O I：
10.1007/s11428-015-1408-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：413 / 414
页数：2
相关论文
共 50 条
  • [41] Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans
    Delgado-Aros, S
    Kim, DY
    Burton, DD
    Thomforde, GM
    Stephens, D
    Brinkmann, BH
    Vella, A
    Camilleri, M
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2002, 282 (03): : G424 - G431
  • [42] GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYY release in humans
    Näslund, E
    Bogefors, J
    Skogar, S
    Grybäck, P
    Jacobsson, H
    Holst, JJ
    Hellström, PM
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 1999, 277 (03) : R910 - R916
  • [43] Erythromycin antagonizes the inhibition of gastric emptying by GLP-1 and unmasks it postprandial insulinotropic across.
    Nauck, MA
    Grosser, S
    Kemmeries, G
    Orskov, C
    Holst, JJ
    Schmiegel, W
    DIABETOLOGIA, 1996, 39 : 591 - 591
  • [44] Increased gallbladder emptying and reduced GLP-1 response in pregnancy with and without gestational diabetes mellitus
    Gether, Ida M.
    Andersen, Emilie S.
    Foghsgaard, Signe
    Ellegaard, Anne-Marie
    Kelstrup, Louise
    Sonne, David P.
    Bronden, Andreas
    Gillum, Matthew P.
    Holst, Jens J.
    Hartmann, Bolette
    Rehfeld, Jens F.
    Vilsboll, Tina
    Knop, Filip K.
    DIABETES OBESITY & METABOLISM, 2024,
  • [45] Erythromycin, but not metoclopramide, domperidone, or cisapride antagonize the inhibition of gastric emptying by GLP-1 in healthy volunteers
    Nauck, MA
    Grosser, S
    Kemmeries, G
    Orskov, C
    Holst, JJ
    Schmiegel, W
    GASTROENTEROLOGY, 1996, 110 (04) : A723 - A723
  • [46] Human amylin, pramlintide and GLP-1: Influence on gastric emptying, appetite and food intake in humans
    Asmar, Meena
    Knop, Filip K.
    Bache, Michael
    Vilsboll, Tina
    Madsbad, Sten
    Holst, Jens J.
    DIABETES, 2008, 57 : A406 - A407
  • [47] Exaggerated postprandial GLP-1 secretion following esophagectomy is not associated with gastric emptying and intestinal transit
    Murphy, C. F.
    Elliott, J. A.
    Docherty, N. G.
    Mohamed, A. A.
    Vincent, R. P.
    Ravi, N.
    Reynolds, J., V
    le Roux, C. W.
    DISEASES OF THE ESOPHAGUS, 2021, 34 (07)
  • [48] GLP-1 and liraglutide increase the platelet inhibitory effects of nitric oxide
    Russo, I.
    Barale, C.
    Mattiello, L.
    Cavalot, F.
    Trovati, M.
    DIABETOLOGIA, 2013, 56 : S397 - S398
  • [49] Inhibitory effect of GLP-1 on gastric motility persists after vagal deafferentation in pigs
    Nagell, Carl Frederik
    Wettergren, Andre
    Orskov, Cathrine
    Holst, Jens Juul
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2006, 41 (06) : 667 - 672
  • [50] Pagoniste effects of GLP-1 receptor (GLP-1R) lixisenatide once daily on gastric emptying and the use of dietary carbohydrates on animatut models: comparison with Liraglutide
    Werner, U.
    Kuhlmann-Gottke, J.
    Schafer, H. L.
    Herling, A. W.
    DIABETES & METABOLISM, 2012, 38 : A97 - A98
12345